Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: July 2022

MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Samsung Mexico SDS Contract Award

Freight Technologies (NASDAQ: FRGT), a technology company developing solutions to optimize and automate the supply chain process as well as providing a platform for B2B cross-border shipping in the NAFTA region, has been awarded a contract with Samsung Mexico in … Continue reading

Posted in Freight Technologies Inc. FRGT | Leave a comment

MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Committed to Becoming Prominent International Player in Lidar Space

Cepton (NASDAQ: CPTN) recently opened a newly renovated office in Metro Detroit (Troy, Michigan). The office is intended to enable the company to continue to forge close relationships with automakers centered around the heart of the U.S. auto industry. “Having … Continue reading

Posted in Cepton Inc. CPTN | Leave a comment

MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Leveraging Sapientus Division to Expand into Big Data Services

FingerMotion (NASDAQ: FNGR) is building a deeper channel for revenue in its services for China’s mobile phone users and big data clients. “FingerMotion’s central competencies are in mobile payment and mobile recharge platform solutions, but the company has been expanding … Continue reading

Posted in FingerMotion Inc. FNGR | Leave a comment

MissionIRNewsBreaks – DPCM Capital Inc.’s (NYSE: XPOA) Pending SPAC Merger Target D-Wave Forms Alliance with Mastercard (NYSE: MA) to Champion Quantum Computing Solutions

DPCM Capital (NYSE: XPOA) recently entered into a definitive transaction agreement with D-Wave Systems Inc., whereby, upon closing of the transaction, shares of the pending parent company – D-Wave Quantum Inc. – are expected to trade on the NYSE under … Continue reading

Posted in DPCM Capital Inc. XPOA | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Urges Shareholders to Vote in Favor of Proxy Proposals for Upcoming Annual Meeting

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today urged shareholders to vote in favor of the proposals outlined … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Notice of Allowance of 26th Worldwide Patent

Lexaria, a global innovator in drug delivery technology, has developed the patented DehydraTECH(TM) technology which has been the subject of several issued patents Recently, Lexaria reported it had been notified of the allowance of its 26th worldwide patent with a … Continue reading

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on Phase 2 EB Trial

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today provided an update on its phase 2 clinical trial using investigational drug INM-755 cannabinol (“CBN”) cream for the treatment of patients with epidermolysis … Continue reading

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Completes Acquisition of Largest-Ever DMT Study

Data from newly acquired study could accelerate clinical development of CYBN’s CYB004 by nine months The pivotal study was designed with four primary objectives Cybin’s proprietary substance has potential to effectively treat anxiety disorders, including GAD and SAD Cybin (NEO: … Continue reading

Posted in Cybin Inc. CYBN | Leave a comment

MissionIRNewsBreaks – Why QSAM Biosciences Inc. (QSAM) Is ‘One to Watch’

QSAM Biosciences (OTCQB: QSAM), a clinical-stage biotechnology company, is focused on bringing to market targeted therapeutic radiopharmaceuticals. “The company is committed to advancing the fight against cancer through the discovery, development and delivery of effective treatment options for adult and … Continue reading

Posted in QSAM Biosciences Inc. QSAM | Leave a comment

MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) and Colombian Senator Fighting to Legalize Recreational Cannabis Meet

Flora Growth’s (NASDAQ: FLGC) CEO Luis Merchan recently met with Senator Gustavo Bolivar, a Colombian representative who introduced a bill that creates the framework for recreational cannabis in the state. The bill was introduced on July 20, 2022, the same … Continue reading

Posted in Flora Growth Corp. FLGC | Leave a comment